从业简历

广东揭阳惠来人2011年获得南方医科大学（原第一军医大学）临床医学学士；2011就读中山大学肿瘤医院\/中山大学肿瘤防治中心胸外科硕士研究生；师从国内著名胸外科专家、食管癌和肺癌首席专家-戎铁华教授，熟练掌握食管癌和肺癌的综合治疗；师从著名胸外科专家，广东省食管癌研究所所长-傅剑华教授，熟练掌握食管癌和肺癌的微创治疗。2014年留校工作，于中山大学附属第一医院胸外科当任住院医师2017-12-31至今 主治医师；社会兼职：1、1.深圳市潮医健康促进中心（潮医会，民政局注册）理事兼秘书长2.中国老年保健医学研究会南方养生养老保健分会 委员3.广东省潮人联健康委青年专家委员会常委；4、中山大学惠来校友会筹备委员会委员，广州地区召集人之一5.惠来中学广州地区校友会 名誉理事科研工作：专攻胸部肿瘤如肺癌，食管癌等手术微创治疗及综合治疗。至今已发表国际SCI论著共23篇，其中第一作者\/通讯作者11篇，总影响因子35分，包括BJC、ASO等著名国际肿瘤杂志。曾多次在世界食管疾病大会、CSCO等国际国内会议作大会发言或壁报展示。至今已发表国外各大著名杂志：1.Zhang SS, Yang H, Luo KJ, et al. The impact of body mass index on complication and survival in resected oesophageal cancer: a clinical-based cohort and meta-analysis. British Journal of Cancer（IF: 5.082）2013. 109(11):2894-903;2.Zhang SS, Huang QY, Yang H, et al. Correlation of p53 status with the response to chemotherapy-based treatment in esophageal cancer: A meta-analysis. Annals of Surgical Oncology (IF: 4.12) 2013 .20（7）：2419-27;3.Zhang SS, Wen Jing, Yang Fu, et al. High expression of Transient potential receptor C6 correlated with poor prognosis in patients with esophageal squamous cell carcinoma. Medical oncology（IF:2.147）.2013. 20（3）：607;4.Zhang SS, Yang Hong, Xie Xuan, et al. Adjuvant chemotherapy versus surgery-alone for esophageal squamous cell carcinoma: a meta-analysis of randomized controlled trials and nonrandomized studies. Diseases of the Esophagus (IF: 1.642) 2013. Epub ahead of print;5.Xie Xuan, Zhang SS (共同第一), Wen Jing, et al. Prognostic value of HOXB7 mRNA expression in human oesophageal squamous cell cancer.Biomarker (IF: 1.879) 2013. 18(4):297-303;6.Xie Xuan, Zhang SS (共同第一), et al. Protein Kinase D1 mRNA level May Predict Cancer-specific Survival in Heavy-smokers with Esophageal Squamous Cell Cancers. Diseases of the Esophagus(IF: 1.642) 2013. Epub ahead of print;7.Hu Wei, Liang Yayong, Zhang SS, Hu Yi, and Liu Jingeng. Impact of subcarinal dissection on short-term outcome and survival following esophagectomy. Am J Surg 2012 (IF:2.516). 2013.206(3):314-98.Zhu YH, Yang F, Zhang SS, Zeng TT, Xie X, Guan XY. High expression of biglycan is associated with poor prognosis in patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol(IF：2.242). 2013 .6(11):2497-505;9.Wen J, Hu Y, Luo KJ, Yang H, Zhang SS, Fu JH.Positive transforming growth factor-β activated kinase-1 expression has an unfavorable impact on survival in T3N1-3M0 esophageal squamous cell carcinomas. Ann Thorac Surg(IF：3.741). 95(1):285-90. 2013.10.Hu W, Liang Y, Zhang SS, Hu Y, Liu J. The significance of subcarinal dissection in esophageal cancer surgery. Asia Pac J Clin Oncol (IF: 0.907). 2013 Aug 5. Epub ahead of print.11.Hu W, Liang Y, Zhang SS, Hu Y, Liu J. Ten-year survival of patients with oesophageal squamous cell carcinoma.S Afr J Surg(IF: 0.362). 2013 May 3;51(2):62-6

擅长领域

擅长肺癌、食管癌、纵膈肿瘤的综合治疗，尤其腔镜微创治疗以及肺癌的化疗和靶向治疗，熟练掌握手足多汗症、肺大泡、气胸、漏斗胸、胸腺瘤等手术治疗。